Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04053335 · ClinicalTrials.gov registry record

Smarter Care Virginia, Examining Low-Value Care in Virginia

A clinical trial, sponsored by University of California, Los Angeles.

Completed
Registry status
5,000,000
Enrollment target

NCT04053335: Completed study, sponsored by University of California, Los Angeles.

NCT04053335 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 5,000,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04053335 has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
5,000,000 participants
Enrollment target

Study Summary

Low-value care is defined as patient care that provides no net benefit to patients in specific clinical scenarios, and can cause patient harm. Prior research has documented high-rates of low-value care in Virginia; this work has helped to inspire a Virginia government-sponsored quality improvement initiative to reduce low-value care. Funded by an Arnold Ventures grant, six large health systems in Virginia volunteered to partner with the Virginia Center for Health Innovation (VCHI) to reduce use of nine low-value health services (three preoperative testing measures, two cardiac screening measures, one diagnostic eye imaging measure, one low-back pain opioid measure, one low-back pain imaging measure and one peripherally inserted central catheter \[PICC\] measure). These health systems include nearly 7000 clinicians practicing across more than 1000 sites. VCHI is implementing a nonrandomized physician peer-comparison feedback quality improvement intervention to reduce use of nine low-value services. Modeling will be used to identify and use propensity score matching to match six intervention health systems to six comparable control health systems. VCHI will provide education, quality improvement training and financial resources to each site, and VCHI will use the Milliman MedInsight Health Waste Calculator to create the peer comparison reports using the Virginia All Payer Claims Database (APCD). VCHI will use additional measures from The Agency for Healthcare Research and Quality (AHRQ). Additionally, VCHI will use AHRQ data to attribute physicians and health care facilities to health systems. The primary purpose of the initiative is to improve quality of care for Virginia residents and this initiative is not being done for research purposes. Nevertheless, University of California, Los Angeles (UCLA) plans to rigorously study and publish the impact of this intervention across the state of Virginia, which is why the UCLA team pre-registered the initiative. The UCLA t

Primary Outcome

Measures defined using evidence-based guidelines such as the USPSTF, American College of Cardiology, Choosing Wisely and others. The primary measure is global percentage of use among eligible patients across 9 measures (see eligibility criteria for measure-specific denominators): * Preoperative laboratory testing * Preoperative EKGs, chest x-rays and pulmonary function testing * Preoperative cardiac imaging/stress testing * Annual EKG/other cardiac screening for low-risk adults * Cardiac stres

Interventions

  • BEHAVIORAL Multicomponent Physician Performance Peer-Comparison Feedback Intervention

Trial Details

FieldValue
Enrollment Target 5,000,000 participants
Start Date 2019-07-25
Est. Completion 2022-12-31

What the finished NCT04053335 record still lists

NCT04053335 is an observational study that tracks outcomes without assigning an intervention. Its 5,000,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 1 intervention - of which Multicomponent Physician Performance Peer-Comparison Feedback Intervention is the first listed.

NCT04053335 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04053335 about?

NCT04053335 is a clinical study titled "Smarter Care Virginia, Examining Low-Value Care in Virginia". Low-value care is defined as patient care that provides no net benefit to patients in specific clinical scenarios, and can cause patient harm. Prior research has documented high-rates of low-value care in Virginia; this work has helped to inspire a Virginia government-sponsored quality improvement i...

What is the current status of trial NCT04053335?

This trial is currently completed. The enrollment target is 5,000,000 participants. The study started on 2019-07-25. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04053335?

The interventions under investigation include: Multicomponent Physician Performance Peer-Comparison Feedback Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04053335?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02693223 · 3,892,063 participants

    Get With the Guidelines-Stroke Registry

  • NCT06803498 · 3,000,000 participants

    Delivery Room Intervention and Evaluation Network

  • NCT03813862 · 2,000,000 participants

    Observational Pharmaco-Epidemiology Research & Analysis

  • NCT06057181 · 2,000,000 participants

    Helix Research Network

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04053335, the US trial registry maintained by the National Library of Medicine. NCT04053335 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.